Drug Act 1978 of Nepal: A Critical Analysis

Authors

  • Nabin Pathak Pokhara University
  • Bijaya Basyal Pokhara University
  • Prabhat Jha Pokhara University
  • Ujjwal Yadav Pokhara University
  • Badri Karki Pokhara University
  • Supriya Jha Pokhara University
  • Mamata Chalise Pokhara University
  • Nisha Kunwar Pokhara University
  • Samikshya Adhikari Pokhara University
  • Sabita Ojha Pokhara University
  • Anil Giri Pokhara University

DOI:

https://doi.org/10.61814/jkahs.v5i3.759

Keywords:

Act; Cosmetics; DDA; Drug; Nepal

Abstract

Background: With the enactment of the Drug Act in 1978, through the establishment of different bodies under the act, drug-related activities have been regulated and controlled in Nepal so as to provide safe and efficacious drugs of standard quality to the general public.  However, with the overgrowing use of drugs, cosmetics, biotechnological products, nutraceuticals, and veterinary products in the present market and the present act failing to include these aspects, this paper tries to critically analyze the Drug Act 1978 of Nepal which will comprise strengths, weaknesses, opportunities, and threats faced in current scenario regarding the act. The regulation of drugs in Nepal was started with the enactment of the Drugs Act in 1978 AD, which is being carried out by the Department of Drug Administration as provisioned in the section 5 of the act. To facilitate the proper implementation of the act, various rules, regulations and guidelines are framed. The objective of this study was to explore the areas to improve in the Drugs Act and help foster the use of safe, efficacious and quality drugs.

Method: The Drugs Act 1978 was critically analyzed focusing on the strengths, weaknesses, opportunities, and threats of the act as of current scenario.

Result: After critically analyzing the drugs act 1978 we found out that there is lack in regulations of use of cosmetics, newer biotechnology products, nutraceuticals, veterinary product, innovative pharmaceutical products as well as the online pharmacy services.

Conclusion: A major amendment and periodic revision is required with the consequence of meeting timely needs and promoting the idea of safety and efficacy in drug related activities.

Downloads

Published

2022-12-31

How to Cite

1.
Pathak N, Basyal B, Jha P, Yadav U, Karki B, Jha S, Chalise M, Kunwar N, Adhikari S, Ojha S, Giri A. Drug Act 1978 of Nepal: A Critical Analysis : . Journal of Karnali Academy of Health Sciences [Internet]. 2022Dec.31 [cited 2024May10];5(3). Available from: https://jkahs.org.np/jkahs/index.php/jkahs/article/view/759

Issue

Vol. 5 No. 3 (2022): JKAHS; Sep-Dec Issue (15)

Section

Commentaries

License

Copyright (c) 2022 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).

Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).

More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below:  https://creativecommons.org/licenses/by/4.0/